Karyopharm Therapeutics Inc. (KPTI)
Market Closed
17 Jul, 20:00
$
9. 51
+0.13
+1.3859%
$
227.76M Market Cap
- P/E Ratio
- Div Yield
202,600 Volume
-1.17 Eps
$ 9.38
Previous Close 
Want to track KPTI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Karyopharm Therapeutics Inc. (KPTI) Statistics
Valuation metrics
Market Cap 227.76M
Enterprise value 355.55M
Trailing P/E (ttm) -0.64
Forward P/E -1.98
PEG ratio 0.01
Price/Sales (ttm) 1.43
Price/Book (mrq) -0.79
Enterprise Value/Revenue 2.35
Enterprise Value/EBITDA -2.4
Overview
Shares outstanding 18.31M
Float 15.08M
Shares short 5.72M
% Held by insiders 0.04%
% Held by institutions 0.58%
Average volume (10 days) 180.76K
Average volume (90 days) 432.49K
Price summary
52-Week low 3.65
52-Week high 10.99
Beta 0.4
50-Day moving average 9.41
200-Day moving average 7.97
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 26 Feb 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.29%
Operating margin -0.56%
Operational effectiveness
Return on assets -1.48%
Return on equity 0.73%
Income Statement
Revenue (ttm) 146.07M
Revenue per share (ttm) 6.86
Quarterly revenue growth (yoy) 0.12%
Gross profit (ttm) 14.5M
EBITDA -90.41M
Net income to common (ttm) -196.04M
Diluted EPS (ttm) -8.86
Quarterly earnings growth (yoy) 0.12%
Balance Sheet
Total cash (mrq) 63.74M
Total cash per share (mrq) 4.13
Total debt (mrq) 305.94M
Total Debt/Equity (mrq) -0.87
Current ratio (mrq) 1.08%
Book value per share (mrq) -12.07
Cash Flow
Cash flow statement -75.37M
Levered free cash flow (LFCF) -49.43M
